Mounjaro is tirzepatide, approved for type 2 diabetes. Zepbound is tirzepatide, approved for weight management. Same molecule, same manufacturer, two brands, two indications.
Using Mounjaro to lose weight is off-label. It is legal, common and a prescriber's call, and there is a specific reason it happens that is worth understanding.
Unlike the semaglutide pair, there is no ceiling
This is where the tirzepatide story differs from the semaglutide one, and most pages treat them as the same situation.
Ozempic stops at 2 mg while Wegovy continues to 2.4 mg, so someone using the diabetes brand for weight eventually runs out of ladder and has to switch. Mounjaro and Zepbound both reach 15 mg. There is no strength you can only get on one of them.
So if you are on Mounjaro for weight, nobody is going to move you to Zepbound because you need a higher dose. The reasons people switch are coverage and cash price, which are administrative rather than clinical.
Why people end up on Mounjaro for weight anyway
Coverage, almost always. Plans that pay for a diabetes medicine frequently will not pay for a weight-management one, and the two brands sit in different formulary categories despite being the same drug. That is worth checking rather than assuming: what the major insurers publish differs a lot between the two indications.
Does tirzepatide actually work better?
Against semaglutide, in the one trial that put them head to head, yes:1
at 72 weeks, the least-squares mean percent change in body weight was −20.2% for tirzepatide users vs. −13.7% for semaglutide users (p<0.001)
American College of Cardiology on SURMOUNT-5
That trial used tirzepatide at 10 or 15 mg against semaglutide at 1.7 or 2.4 mg in adults with obesity and without diabetes, so it is more precisely a Zepbound-versus-Wegovy result. We wrote out what that trial does and does not settle separately.
Taking it
From the FDA label:2
Administer ZEPBOUND once weekly at any time of day, with or without meals. Rotate injection sites with each dose.
FDA label, via DailyMed
One detail specific to tirzepatide, and it surprises people: the label says the back of the upper arm should be injected by another person. Semaglutide's label does not say that. Worth knowing if you have been doing your own arm.
What tirzepatide costs
The honest summary
Mounjaro and Zepbound are the same drug at the same strengths with different labels on the box. If you are using the diabetes one for weight, you are not missing out on dose, and the question worth asking your prescriber and your insurer is purely which brand costs you less. That is a rarer situation than it sounds, and it is genuinely good news.